Fierce Pharma

JUNE 17, 2024

The FDA has approved the world’s first pneumococcal disease vaccine designed for adults, signing off on Merck’s Capvaxive (formerly V116) and positioning it to become the primary shot used by senio | The FDA has approved the world’s first pneumococcal disease vaccine designed for adults, signing off on Merck’s Capvaxive (formerly V116) and positioning it to become the primary shot used by seniors to protect against the bacterial infection.

FDA 317

FDA 317

MedCity News

JUNE 17, 2024

Two senators recently introduced a bill that seeks to regulate private equity firms’ involvement in the healthcare industry. If passed, the act would establish a criminal penalty of up to six years in prison for private equity executives whose business decisions result in a patient’s death. The post If Passed, This New Bill Could Send PE Execs to Jail for Hospital Mismanagement appeared first on MedCity News.

Healthcare 139

Healthcare Healthcare 139

Fierce Pharma

JUNE 17, 2024

Two back-to-back pivotal trial wins have rekindled hopes at GSK that once-failed multiple myeloma drug Blenrep could reach more than 3 billion pounds sterling in peak sales after all. | Two back-to-back pivotal trial wins have rekindled hopes at GSK that once-failed multiple myeloma drug Blenrep could reach more than 3 billion pounds sterling in peak sales after all.

Sales 276

Sales Marketing 276

Pharmaceutical Technology

JUNE 17, 2024

Novavax has sought US FDA approval for an updated JN.1 version of its Covid-19 vaccine, NVX-CoV2705, for individuals aged 12 years and above.

FDA 145

FDA 145

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

JUNE 17, 2024

Novo Nordisk CEO Lars Fruergaard Jorgensen has agreed to face questions at a Senate hearing in September after Sen. | Novo Nordisk CEO Lars Fruergaard Jorgensen has agreed to face questions at a Senate hearing in September after Sen. Bernie Sanders, I-Vermont, threatened to subpoena the company over its pricing of popular weight loss drugs Ozempic and Wegovy.

237

237

Impetus Digital

JUNE 17, 2024

A version of this article was previously published in the Journal of mHealth. The days of cookie-cutter medical education sessions and unengaging, didactic data presentations are–mostly–over. These days, medical education and training programs are all about customization, personalization, and innovation. In this article, we take a look at 10 of the hottest trends in medical education and learning programs. 1.

Education 109

Education Medical Training Media 109

MedCity News

JUNE 17, 2024

Takeda Pharmaceutical’s soticlestat did not meet Phase 3 goals in Dravet syndrome and Lennox-Gastaut syndrome, two rare forms of epilepsy. But the pharma giant points to results on secondary goals and subgroup analyses, and plans to discuss with regulators the “totality of data.” The post Takeda Drug Fails Pivotal Tests in 2 Rare Epilepsies; Path Forward Depends on Regulatory Flexibility appeared first on MedCity News.

Pharma 110

Pharma Pharmaceutical Biopharma 110

Fierce Pharma

JUNE 17, 2024

The failure of Marinus Pharmaceuticals’ trial for ganaxolone as a treatment for persistent seizures has left the Philadelphia company facing the daunting prospect of conducting a new study to | The failure of Marinus Pharma’ trial for ganaxolone as a treatment for persisting seizures has left the Philadelphia company facing the daunting prospect of conducting a new study to keep its hopes alive in the indication.

Prospecting 216

Prospecting Pharma Pharmaceutical 216

MedCity News

JUNE 17, 2024

We recently spoke with Nicole Bulochnik, senior vice president of drug strategy for Abarca, about what payers need to consider as demand for this group of weight-loss drugs remains high. The post Are GLP-1 Drugs Here to Stay? appeared first on MedCity News.

104

104

Fierce Pharma

JUNE 17, 2024

Six weeks after revealing that an interim analysis of a phase 3 trial showed that AstraZeneca’s blood cancer drug Calquence plus chemoimmunotherapy worked in previously untreated mantle c | In the ECHO study, adding Calquence to the chemotherapy combination of bendamustine and rituximab reduced the risk of disease progression or death by 27%. And there's a positive trend in overall survival.

158

158

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

European Pharmaceutical Review

JUNE 17, 2024

Johnson & Johnson Innovative Medicine is planning to invest a total of €580 million in Italy over the next five years. A portion of the investment, €125 million, is intended to support greater production capacity at its Latina site, which is a key part of the firm’s worldwide supply chain network, the company stated. For example, the plant produces over four billion tablets every year, spanning approximately 30 different products, J&J confirmed.

Medicine 97

Medicine Manufacturing Management Government 97

Fierce Pharma

JUNE 17, 2024

As argenx homes in on the next indication for its pipeline-in-a-product Vyvgart (efgartigimod), the company is preparing for the next leg of its commercial journey. | As part of Vision 2030, argenx will touch on its continuing commitment to tackle severe autoimmune diseases with Vyvgart. The company also plans to highlight its next potential commercial product empasiprubart and its broader antibody-based pipeline.

130

130

Pharmaceutical Commerce

JUNE 17, 2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

Distribution 103

Distribution Biopharma Pharma Patients 103

Fierce Pharma

JUNE 17, 2024

AstraZeneca’s Imfinzi has followed GSK’s Jemperli into endometrial cancer. And like its compatriot competitor, the FDA approval is limited to a subgroup of patients. | AstraZeneca’s Imfinzi has followed GSK’s Jemperli into endometrial cancer with a limited FDA nod. Two questions remain for the PD-1/L1 inhibitor class in the broader endometrial cancer field.

FDA 130

FDA Patients 130

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

MedCity News

JUNE 17, 2024

During a panel discussion at AHIP 2024, several executives shared their healthcare calls to action, including leveraging AI and rebuilding trust. The post Healthcare Execs’ Urgent Calls To Action appeared first on MedCity News.

Healthcare 83

Healthcare Healthcare 83

pharmaphorum

JUNE 17, 2024

Two executives at telehealth startup Done Global have been arrested and face allegations of fraud involving the distribution of medicines for ADHD

Distribution 110

Distribution Medicine 110

PharmaTimes

JUNE 17, 2024

Cancer was estimated to be responsible for more than 18 million cases worldwide in 2020

Patients 111

Patients 111

pharmaphorum

JUNE 17, 2024

Takeda’s experimental epilepsy drug soticlestat has failed phase 3 trials in Dravet syndrome and Lennox-Gastaut syndrome

111

111

Advertisement

MedCity News

JUNE 17, 2024

5G can play a substantial role in transforming healthcare delivery by fostering care anywhere. The post Why Conditions are Ripe for Enabling Care Everywhere appeared first on MedCity News.

Healthcare 73

Healthcare Healthcare Patients 73

pharmaphorum

JUNE 17, 2024

Sanofi and Innate Pharma NK cell engager therapy SAR443579 shows promising efficacy in AML patients in a phase 1/2 trial reported at EHA.

Pharma 114

Pharma Patients 114

Pharmaceutical Technology

JUNE 17, 2024

Daxdilimab is under clinical development by Amgen and currently in Phase II for Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE).

75

75

pharmaphorum

JUNE 17, 2024

Stanford Medicine study finds risk of secondary cancers with CAR-T therapies is low and likely unrelated to the treatments themselves

Medicine 105

Medicine 105

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmaceutical Technology

JUNE 17, 2024

Apalutamide is under clinical development by Johnson & Johnson and currently in Phase III for Metastatic Castration-Resistant Prostate Cancer (mCRPC).

75

75

PharmaTimes

JUNE 17, 2024

Medulloblastoma is responsible for around 52 new cases in children in the UK every year

94

94

Pharmaceutical Technology

JUNE 17, 2024

MAS-825 is under clinical development by Novartis and currently in Phase II for Coronary Artery Disease (CAD) (Ischemic Heart Disease).

76

76

PharmaTech

JUNE 17, 2024

Gabi Hanna, MD, CEO and co-founder of Lamassu Pharma talks about a novel oncology platform and the link between science and patient care.

Pharma 69

Pharma Patients 69

Advertisement

Distribution

Pharmaceutical Technology

JUNE 17, 2024

OCT-461201 is under clinical development by Oxford Cannabinoid Technologies and currently in Phase I for Neuropathic Pain (Neuralgia).

76

76

Pharmaceutical Commerce

JUNE 17, 2024

A cross-sectional study among patients with both cancer and a SARS-CoV-2 infection investigates if there were racial and ethnic disparities in treatment delays or discontinuations.

Patients 52

Patients 52

Pharmaceutical Technology

JUNE 17, 2024

Ferric carboxymaltose is under clinical development by Vifor Pharma Management and currently in Phase III for Restless Legs Syndrome.

Management 75

Management Pharma 75

Pharmaceutical Commerce

JUNE 17, 2024

In an interview with Pharma Commerce Editor Nicholas Saraceno, Fran Gregory, PharmD, Vice President of Emerging Therapies, Cardinal Health discusses the growing biosimilars market and the challenges associated with regulation and adoption.

Pharma 52

Pharma Marketing 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales